Steven Cook Sells 17,950 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 17,950 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $18.13, for a total value of $325,433.50. Following the completion of the transaction, the chief financial officer owned 169,259 shares of the company’s stock, valued at $3,068,665.67. The trade was a 9.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Omada Health Stock Up 1.5%

OMDA traded up $0.28 during trading on Wednesday, reaching $18.58. 706,805 shares of the company’s stock were exchanged, compared to its average volume of 1,201,429. The company has a market capitalization of $1.10 billion and a P/E ratio of -68.81. The business has a 50 day moving average price of $16.09 and a 200 day moving average price of $14.79. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. As a group, research analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have commented on OMDA shares. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Needham & Company LLC reissued a “buy” rating and issued a $28.00 target price on shares of Omada Health in a report on Friday, May 8th. Wall Street Zen downgraded Omada Health from a “buy” rating to a “hold” rating in a research report on Saturday, May 30th. Barclays boosted their price target on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Finally, BMO Capital Markets dropped their price objective on Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Ten research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $22.91.

Institutional Trading of Omada Health

Several hedge funds have recently modified their holdings of OMDA. Raymond James Financial Inc. acquired a new position in shares of Omada Health in the 2nd quarter worth approximately $32,000. Bellevue Group AG increased its holdings in Omada Health by 0.7% during the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after purchasing an additional 1,791 shares in the last quarter. Quarry LP acquired a new stake in Omada Health during the 4th quarter valued at $29,000. Barclays PLC raised its position in Omada Health by 14.6% in the 4th quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after purchasing an additional 1,888 shares during the last quarter. Finally, TD Waterhouse Canada Inc. acquired a new position in Omada Health in the fourth quarter worth $32,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.